Skip to content
← Full study record

NCT00782379 · OUTCOME

Non-relapse Mortality at 1 Year After Peripheral Blood Stem Cell Transplantation (PBSCT)

Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer · Source last updated 2013-11-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
1 year

What was measured

Non-relapse mortality refers to whether a patient dies of causes related to something other than the primary disease.

Analysis population: 6 patients died prior to one year and therefore are eligible to be evaluated for non-relapse mortality.

Groups in this outcome

Haploidentical Transplant

Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Haploidentical Transplant6

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Haploidentical Transplant2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      6
    units
    Participants
description
Non-relapse mortality refers to whether a patient dies of causes related to something other than the primary disease.
groups
  1. description
    Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant
    id
    OG000
    title
    Haploidentical Transplant
param Type
NUMBER
population Description
6 patients died prior to one year and therefore are eligible to be evaluated for non-relapse mortality.
reporting Status
POSTED
time Frame
1 year
title
Non-relapse Mortality at 1 Year After Peripheral Blood Stem Cell Transplantation (PBSCT)
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice